Intellectual Property Week 2 Nptel Assignment Answers 2026
Are you looking for Intellectual Property Week 2 Nptel Assignment Answers 2026 ? You’ve come to the right place! Access the most accurate answers at Progiez.
Table of Contents
Intellectual Property Week 2 Nptel Assignment Answers (Jan-Apr 2026)
Que.1
The turnover of a startup should not exceed:
a) 25 crores within the 5 year period
b) 25 crores within the 7 year period
c) 20 crores within the 5 year period
d) 20 crores within the 7 year period
Que.2
A Patent for a new form of a known substance can be granted only:
a) When new substance is an isomorphic form of the known substance
b) When the new substance is a new salt of the known substance
c) When the new substance shows enhanced efficacy
d) None of the above
Que.3
The ability of mass duplication in intangible assets exists because of the trait:
a) Sunkenness
b) Scalability
c) Liquidity
d) None of the above
Que.4
Startup is considered as an entity if:
a) It is working towards innovation, development, improvement of product or process or services
b) It is working towards commercialization or marketing of product or process or services
c) It is working only towards a particular technology
d) None of these
Que.5
Statement 1: An entity shall cease to be a startup on completion of 7 years from the date of its incorporation/registration.
Statement 2: In respect of Startups in the biotechnology sector, an entity shall cease to be a Startup on completion of 10 years from the date of its incorporation/registration.
a) Statement 1 is True and Statement 2 is False
b) Statement 1 is False and Statement 2 is True
c) Both Statement 1 and 2 are True
d) Both Statement 1 and 2 are False
Que.6
Statement 1: “Synergies” in intangibility refers to the fact that the benefit of an intangible asset may accrue on others.
Statement 2: Strong IP rights increase investment.
a) Statement 1 is True and Statement 2 is False
b) Statement 1 is False and Statement 2 is True
c) Both Statement 1 and 2 are True
d) Both Statement 1 and 2 are False
Que.7
Some of the grounds pertaining to the rejection of the Novartis patent are:
a) Not an invention under section 3(d)
b) Non-disclosure of biological material
c) Anticipation
d) Lack of inventive step
Que.8
The traits of intangibility include:
a) Volatile
b) Spillovers
c) Sunkenness
d) Scalability
Que.9
Which of the following falls under intangible investments?
a) New technological ideas
b) New Product designs
c) New Business Models
d) Codified information
Que.10
In the Novartis case, the Patent was rejected on the following grounds:
a) Anticipation
b) Non-obviousness
c) Not an invention
d) Wrongful Priority
Jan-Apr 2025
Course Link: Click Here
1. The turnover of a startup should not exceed
- 25 crores within the 5 years period
- 100 crores within the 10 years period
- 20 crores within the 5 years period
- 20 crores within the 7 years period
2. Novartis patent was for-
- Beta crystalline form of Imatinib Mesylate.
- Alpha crystalline form of Imatinib Mesylate.
- Gamma crystalline form of Imatinib Mesylate.
- None of the above
3. The ability of mass duplication in intangible assets exists because of the trait:
- Sunkenness
- Scalability
- Liquidity
- None of the above
4. Definition of start-Up is in
- Rule 2 f(b)
- Rule 4 a
- Rule 20
- Rule 16
5. Statement 1: An entity shall cease to be a startup on completion of 7 years from the date of its incorporation/registration.
Statement 2: In respect of Startups in the biotechnology sector, an entity shall cease to be a Startup on completion of 7 years from the date of its incorporation/registration.
- Statement 1 is True and Statement 2 is False
- Statement 1 is False and Statement 2 is True
- Both Statement 1 and 2 are True
- Both Statement 1 and 2 are False
6. Statement 1: “Synergies” in intangibility refers to the fact that the benefit of an intangible asset may accrue on others.
Statement 2: Strong IP rights increase investment and reduce synergies and leads to Patent thickets.
- Statement 1 is True and Statement 2 is False
- Statement 1 is False and Statement 2 is True
- Both Statement 1 and 2 are True
- Both Statement 1 and 2 are False
7. The ground pertaining to the rejection of the Novartis patent is:
- Not an invention under section 3(d)
- Non-disclosure of biological material
- No-Prior art found
- Lack of inventive step
8. FRAND license term includes:
- Fair and Reasonable terms
- Non-discriminatory
- Limitation of technology usage
- None of the above
9. Which of the following falls under intangible investments?
- New technological ideas
- New Product designs
- New Business Models
- Ownership of land as asset
10. The Novartis standard established after the judgment is/are:
- Identifying the new form of the known substance
- Comparing the pharmacological properties of the known substance with new form of the known substance
- Provide comparative material on enhanced efficacy
- Lack of inventive step
Intellectual Property Week 2 Nptel Assignment Answers 2025
For answers to others Nptel courses, please refer to this link: NPTEL Assignment